Related Experiment Videos
Rate-limiting diffusion processes following intrathecal administration of morphine
European Journal of Clinical Pharmacology
|January 1, 1986
Summary
Intrathecal morphine offers prolonged analgesia due to slow diffusion into plasma, with complete bioavailability. This pharmacokinetic profile suggests morphine is not metabolized in the central nervous system (CNS).
Area of Science:
- Pharmacology
- Neuroscience
- Clinical Pharmacy
Background:
- Intrathecal (i.t.) administration of analgesics bypasses first-pass metabolism.
- Understanding morphine pharmacokinetics after i.t. administration is crucial for optimizing pain management.
Purpose of the Study:
- To compare morphine pharmacokinetics following intrathecal versus intravenous administration.
- To elucidate the bioavailability and elimination pathways of i.t. morphine.
Main Methods:
- Plasma morphine concentrations were measured using radioimmunoassay (RIA) in patients receiving i.t. or i.v. morphine.
- Pharmacokinetic analysis was performed to determine clearance, bioavailability, and half-life.
Main Results:
- Intrathecal morphine demonstrated complete bioavailability to the systemic circulation.
- Similar apparent total body clearance was observed for both i.t. and i.v. morphine.
- A flip-flop phenomenon contributed to a prolonged terminal half-life for i.t. morphine.
Conclusions:
- Morphine likely does not undergo metabolism within the central nervous system (CNS).
- Slow diffusion from the cerebrospinal fluid (CSF) to plasma explains the extended duration of analgesia after i.t. administration.
- Intrathecal morphine is a viable route for sustained pain relief.